Testing Could Lead to Answers
Tests like echocardiograms, stress tests and coronary angiograms could reveal important details about your patients’ condition, such as the stage of heart failure. And could also uncover the underlying cause of the patient’s heart failure. Testing can detect a condition before it gets worse and help determine the appropriate treatment plan, which may reduce readmissions in your hospital.
Symptoms of Heart Failure and Coronary Artery Disease (CAD)
Fatigue, chest pain, and shortness of breath could be symptoms of heart failure and CAD – symptoms that could be easily overlooked or mistaken for another condition. Additional symptoms, including those specific to women, are also indicators. Being aware of all symptoms, combined with a physical examination, family history understanding, and close patient monitoring, is key in identifying patients who may have undiagnosed heart failure or CAD.
Even Surgical Turndown Patients May Have Options
Often used for shock patients, an Impella CP heart pump-supported outpatient procedure could be an option for high-risk patients suffering from heart failure and CAD. A multidisciplinary approach could determine if this should be performed inpatient, or after discharge as an outpatient. Requesting the right tests is the critical first step towards ensuring potentially life-saving care, which may include Impella CP.
How Impella CP works
Protected PCI with Impella CP is a minimally invasive, outpatient procedure performed by an interventional cardiologist (IC). During the procedure, Impella CP takes over the pumping function of the heart, which makes sure there’s proper blood flow to major organs. This allows the IC to perform procedures that would otherwise be unsafe for patients who are too high risk for surgery. Impella CP is temporary and is removed before the patient goes home.
Support is Nearby
Impella therapy awareness managers (TAMs) provide education on CAD and heart failure and can help you find a treatment for your patient. Your TAM can help you decide if Impella CP could benefit your patients who have complex heart conditions and connect you with an Interventional Cardiologist who performs PCI with Impella CP.
Footnotes
O'Neill, et al. AHJ, 2012 126(14), https://doi.org/10.1161/CIRCULATIONAHA.112.098194
Study was based on Impella 2.5 which is no longer in market and replaced with Impella CP. Findings for Impella 2.5 would be transferable to Impella CP
Lansky, et al. The American Journal of Cardiology, 2022, https://doi.org/10.1016/j.amjcard.2022.08.032
Abu-Much, et al., AHJ, 2024 269:139-148. https:/doi.org/10.1016/j.ahj.2023.12.015
Wollmuth, et al. JSCAI, 2022 1(5), https:/doi.org/10.1016/j.jscai.2022.100350
Zeitouni, et al., Circulation: Cardiovascular Interventions, 2022 15(5). https://doi.org/10.1161/CIRCINTERVENTIONS.121.011534
IMP-5937